Industry
Thought leaders sharing decades of industry experience through publications and research
Latest News
Introducing DTEACH©
Diversity and inclusion are key components of a culturally diverse workplace. It’s important for clinical research site personnel, clinical research associates, as well as project …
ANZ Site Solutions Summit
After two years of virtual meetings due to the COVID-19 pandemic, it was with great pleasure to attend the in-person SCRS ANZ Site Solutions Summit …
Launching Meaningful Change in Diversity, Equity and Inclusion in Clinical Trials: Key Takeaways from the Diversity Site Solutions Summit (Part 2)
By Diana Foster, Ph.D., Vice President, Diversity, Equity, and Inclusion, Society for Clinical Research Sites The life sciences industry can, and should, be a driving …
The Society for Clinical Research Sites (SCRS) First in Kind Diversity Site Solutions Summit
April 13, 2022 – The Society of Clinical Research Sites (SCRS) will be hosting its inaugural Diversity Site Solutions Summit on 20 May 2022 in Austin, Texas. …
Total Diversity Clinical Trial Management Provides Signature Voice Sponsorship for First Site-Focused Diversity Conference in the Clinical Trials Industry
April 12, 2022 – Total Diversity Clinical Trial Management, a global Contract Research Organization and full-service Diversity Organization, is supporting the Society of Clinical Research Sites’ …
Kenyetta Sims Announced as Director of Diversity Training & Education of Total Diversity Clinical Trial Management
March 15, 2022 – Total Diversity Clinical Trial Management, a global Contract Research Organization and full-service Diversity Organization, has announced Kenyetta Sims, MAOM, CCRC as …
Former Surgeon General Jerome Adams Announced as Chairman of the Board of Total Diversity Clinical Trial Management
March 8, 2022 – Total Diversity Clinical Trial Management, a global Contract Research Organization and full-service Diversity Organization, has announced former Vice Admiral Jerome Adams, …
Kim Kundert and Amanda Rangel Join Total Diversity Following the Announcement of Focused Diversity Services
September 30, 2021 – TOTAL Diversity (TOTAL), a woman-owned full service CRO with a long-standing history of recruiting and enrolling diverse populations, has appointed Kim …
Total Clinical Trial Management Announces the Launch of Total Diversity
September 28, 2021 – Total Clinical Trial Management (TCTM), a woman-owned full service CRO, has recently announced a new brand and new focus – TOTAL …
Conferences
2022 SCRS EU Summit
2022 SCRS Global Site Solutions Summit
2022 DIA Advancing Diversity, Equity, and Inclusion Across Life Sciences R&D Meeting
2022 SCRS Australia & New Zealand Site Solutions Summit
Research Articles
TOTAL Diversity’s Response to FDA’s Draft Guidance to Industry Regarding Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations in Clinical Trials
Total Diversity Clinical Trial Management (TOTAL, Dallas Texas) supports efforts to bring all aspects of Diversity into the management of clinical research trials and appreciates …
A Determination of Variables That Impact Research Site Best Practices: An Analysis of Clinical Trial Site Characteristics as Compared to Scores Using the SCRS Diversity Self-Assessment Tool (DSAT)
By Diana Foster, Ph.D., CEO, TOTAL Diversity Clinical Trial Management, Kim Kundert, RN/BSN, Sr. Vice President, Site Development Services, and Jerome Adams, M.D., Chairman of …
Identify Opportunities to Improve Diversity Recruitment
Diana Foster, Ph.D.CEO, Total Diversity Clinical Trials Management While it’s important to note that there are areas where the industry can improve, there are unique …
Consultative Opportunities
Dr. Diana Foster, Ph.D
An innovative leader
Diana Foster is a recognized expert in the intricacies of site management and an innovator in the use of strategic marketing and positioning tactics, her focus and strategic guidance in the area of diversity among clinical trials positions Diana as a continued thought leader related to this critical movement in the clinical trial industry.
